IDG-Accel-backed Kanghui prices in middle of its initial public offering range in New York.

TetraLogic Pharmaceuticals' $32m series C round sees repeat investment from Amgen Ventures.

Safeguard Scientifics and SR One-baved drugs company NuPathe amends listing price to $10 per share.

Merck and Siemens sell out of VisEn Medical in exit to New York-listed medical technology company PerkinElmer.

Pfizer sells Idun to Conatus.

Venture capital firm Latterell Venture Partners added $4m to the $12m raised in April by HemaQuest Pharmaceuticals.

Foundation Venture Capital Group sells stake in Longevica to Russia's Rostock.

Renowned hand surgeon Thomas Graham to lead corporate venturing division of one of the US's largest medical research institutions.

Chinese maker of orthopedic implants backed by US media company International Data Group's local venture fund, IDG-Accel, starts $75m flotation process.